Sartorius Ag Unspadr Stock Net Income

SRT4 Stock  EUR 34.00  0.60  1.80%   
SARTORIUS AG UNSPADR fundamentals help investors to digest information that contributes to SARTORIUS's financial success or failures. It also enables traders to predict the movement of SARTORIUS Stock. The fundamental analysis module provides a way to measure SARTORIUS's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to SARTORIUS stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

SARTORIUS AG UNSPADR Company Net Income Analysis

SARTORIUS's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

More About Net Income | All Equity Analysis

Current SARTORIUS Net Income

    
  336.27 M  
Most of SARTORIUS's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SARTORIUS AG UNSPADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, SARTORIUS AG UNSPADR reported net income of 336.27 M. This indicator is about the same for the Healthcare average (which is currently at 341.28 M) sector and 237.5% higher than that of the Medical Instruments & Supplies industry. The net income for all Germany stocks is 41.11% higher than that of the company.

SARTORIUS Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SARTORIUS's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of SARTORIUS could also be used in its relative valuation, which is a method of valuing SARTORIUS by comparing valuation metrics of similar companies.
SARTORIUS is rated below average in net income category among its peers.

SARTORIUS Fundamentals

About SARTORIUS Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze SARTORIUS AG UNSPADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SARTORIUS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SARTORIUS AG UNSPADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in SARTORIUS Stock

SARTORIUS financial ratios help investors to determine whether SARTORIUS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SARTORIUS with respect to the benefits of owning SARTORIUS security.